Insider · CIK 0001741987
Burnett Patrick
officer
Files at ARQT (Arcutis Biotherapeutics, Inc.). First filing Nov 5, 2024, latest Dec 31, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $1.0M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 3Weak | sell 210b5-1 | ARQT Arcutis Biotherapeutics, Inc. | $24k | 1,691 | -1% | - | |
| 31Weak | sell 4 | ARQT Arcutis Biotherapeutics, Inc. | $163k | 16,023 | -11% | - | |
| 46Moderate | sell 5 | ARQT Arcutis Biotherapeutics, Inc. | $713k | 69,226 | -39% | - | |
| 21Weak | sell 510b5-1 | ARQT Arcutis Biotherapeutics, Inc. | $134k | 15,441 | -8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,691 | $14.00 | $24k | 126,978 | Dec 31, 2024 |
| Nov 22, 2024 | ARQT Arcutis Biotherapeutics, Inc. | MOption exercise Common Stock | +16,023 | $0.00 | $0 | 144,692 | Nov 26, 2024 |
| Nov 22, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock | -16,023 | $10.14 | $163k | 128,669 | Nov 26, 2024 |
| Nov 22, 2024 | ARQT Arcutis Biotherapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -16,023 | $0.00 | $0 | 218,500 | Nov 26, 2024 |
| Nov 14, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock | -50,749 | $10.29 | $522k | 128,669 | Nov 18, 2024 |
| Nov 14, 2024 | ARQT Arcutis Biotherapeutics, Inc. | MOption exercise Common Stock | +18,377 | $0.00 | $0 | 147,046 | Nov 18, 2024 |
| Nov 14, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock | -18,377 | $10.29 | $189k | 128,669 | Nov 18, 2024 |
| Nov 15, 2024 | ARQT Arcutis Biotherapeutics, Inc. | MOption exercise Common Stock | +100 | $0.00 | $0 | 128,769 | Nov 18, 2024 |
| Nov 15, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock | -100 | $10.03 | $1,003 | 128,669 | Nov 18, 2024 |
| Nov 14, 2024 | ARQT Arcutis Biotherapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -18,377 | $0.00 | $0 | 234,623 | Nov 18, 2024 |
| Nov 15, 2024 | ARQT Arcutis Biotherapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -100 | $0.00 | $0 | 234,523 | Nov 18, 2024 |
| Nov 4, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -15,441 | $8.68 | $134k | 179,418 | Nov 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.